To systematically assess these differences and distinguish direct antitumor effects from indirect consequences, RNA-Seq followed by scatter plot analysis could provide deeper insight into EZH2’s role in tumor cell differentiation and therapy response. The gene discussed is EZH2; the disease is neoplasm.